摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Methyl-benzoic acid (2R,3R,4R,5R)-5-(4-benzoylamino-2-oxo-2H-pyrimidin-1-yl)-3-[(2-chloro-phenoxy)-hydroxy-phosphoryloxy]-4-(tetrahydro-pyran-2-yloxy)-tetrahydro-furan-2-ylmethyl ester; compound with triethyl-amine | 137212-08-9

中文名称
——
中文别名
——
英文名称
4-Methyl-benzoic acid (2R,3R,4R,5R)-5-(4-benzoylamino-2-oxo-2H-pyrimidin-1-yl)-3-[(2-chloro-phenoxy)-hydroxy-phosphoryloxy]-4-(tetrahydro-pyran-2-yloxy)-tetrahydro-furan-2-ylmethyl ester; compound with triethyl-amine
英文别名
——
4-Methyl-benzoic acid (2R,3R,4R,5R)-5-(4-benzoylamino-2-oxo-2H-pyrimidin-1-yl)-3-[(2-chloro-phenoxy)-hydroxy-phosphoryloxy]-4-(tetrahydro-pyran-2-yloxy)-tetrahydro-furan-2-ylmethyl ester; compound with triethyl-amine化学式
CAS
137212-08-9
化学式
C6H15N*C35H35ClN3O11P
mdl
——
分子量
841.295
InChiKey
JQBRHASHWYJWRJ-KZMAMCQTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.04
  • 重原子数:
    58.0
  • 可旋转键数:
    15.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    176.98
  • 氢给体数:
    2.0
  • 氢受体数:
    13.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    New regiospecific synthesis of branched tetra-, nona- & deca-RNA modelling the lariat formed in RNA splicing reactions
    摘要:
    Convergent syntheses of branched tetraribonucleotide 39, nonaribonucleotide 40 and decaribonucleotide 41, modelling the lariat of pre-mRNA processing reaction, are reported. The first key step in the present strategy involves the condensation of the phosphodiester blocks 1, 5 or 15 with the 3',5'-dihydroxy-6-N-benzoyl-2'-O-pixyl(9-phenylxanthen-9-yl)adenosine 29 to give 30a (65%), 31a (63%) or 32a (70%). Chemospecific phosphorylation at 3'-OH of these intermediates afforded the intermediates 30b (92%), 31b (83%) or 32b (80%) which were treated with mild acid to achieve a regiospecific removal of the 2'-O-pixyl group to give compounds 30c (74%), 31c (86%) or 32c (85%). The second key step involved the introduction of biscyanoethylphosphotriester moiety to the 2'-OH of the branch-point adenosine in 30c, 31c or 32c in one single step using (biscyanoethoxy)-(diisopropylamino)phosphine to give the crucial branch-point building blocks 30d (46%), 31d (64%) or 32d (62%) with two dissimilar vicinal phosphates at 2'- and 3'- of the branch-point. These blocks were then converted to the fully protected intermediates 33a (59%) [30d+28 --> 33a], 34a (69%) [31d+19 --> 34a] and 35a (56%) [32d+19 --> 35a], and were subsequently treated with a bulky tertiary amine to give the branch-point 2'-cyanoethylphosphodiester blocks 33b (64%), 34b (67%) and 35b (68%). These were then condensed in the usual way with the appropriate 5'-hydroxy block (27 or 25) to give the fully protected branched oligomers 36 (69%) [33b+27 --> 36], 37 (67%) [34b+25 --> 37] and 38 (63%) [35b+25 --> 38]. These oligomers were then deprotected in the usual manner to give the final branched oligoribonucleotides 39, 40 and 41 in 62%, 21% and 21% yields respectively. Detailed 500 MHz H-1-NMR and 202.4 MHz P-31-NMR studies on 39, 40 and 41 have unequivocally established their purities. Detailed spectroscopic studies such as COSY, HOHAHA & NOESY have also clearly established the structural integrity of the synthetic target compounds.
    DOI:
    10.1016/s0040-4020(01)86562-5
  • 作为产物:
    参考文献:
    名称:
    New regiospecific synthesis of branched tetra-, nona- & deca-RNA modelling the lariat formed in RNA splicing reactions
    摘要:
    Convergent syntheses of branched tetraribonucleotide 39, nonaribonucleotide 40 and decaribonucleotide 41, modelling the lariat of pre-mRNA processing reaction, are reported. The first key step in the present strategy involves the condensation of the phosphodiester blocks 1, 5 or 15 with the 3',5'-dihydroxy-6-N-benzoyl-2'-O-pixyl(9-phenylxanthen-9-yl)adenosine 29 to give 30a (65%), 31a (63%) or 32a (70%). Chemospecific phosphorylation at 3'-OH of these intermediates afforded the intermediates 30b (92%), 31b (83%) or 32b (80%) which were treated with mild acid to achieve a regiospecific removal of the 2'-O-pixyl group to give compounds 30c (74%), 31c (86%) or 32c (85%). The second key step involved the introduction of biscyanoethylphosphotriester moiety to the 2'-OH of the branch-point adenosine in 30c, 31c or 32c in one single step using (biscyanoethoxy)-(diisopropylamino)phosphine to give the crucial branch-point building blocks 30d (46%), 31d (64%) or 32d (62%) with two dissimilar vicinal phosphates at 2'- and 3'- of the branch-point. These blocks were then converted to the fully protected intermediates 33a (59%) [30d+28 --> 33a], 34a (69%) [31d+19 --> 34a] and 35a (56%) [32d+19 --> 35a], and were subsequently treated with a bulky tertiary amine to give the branch-point 2'-cyanoethylphosphodiester blocks 33b (64%), 34b (67%) and 35b (68%). These were then condensed in the usual way with the appropriate 5'-hydroxy block (27 or 25) to give the fully protected branched oligomers 36 (69%) [33b+27 --> 36], 37 (67%) [34b+25 --> 37] and 38 (63%) [35b+25 --> 38]. These oligomers were then deprotected in the usual manner to give the final branched oligoribonucleotides 39, 40 and 41 in 62%, 21% and 21% yields respectively. Detailed 500 MHz H-1-NMR and 202.4 MHz P-31-NMR studies on 39, 40 and 41 have unequivocally established their purities. Detailed spectroscopic studies such as COSY, HOHAHA & NOESY have also clearly established the structural integrity of the synthetic target compounds.
    DOI:
    10.1016/s0040-4020(01)86562-5
点击查看最新优质反应信息

同类化合物

齐夫多定相关物质B 齐多夫定 黄质核苷 黄苷5'-(四氢三磷酸酯)三钠盐 黄苷3',5'-环单磷酸酯 黄苷-5'-三磷酸酯 黄嘌呤核苷 鸟苷酸 鸟苷酰-3'-5'-胞苷铵盐 鸟苷酰-(3'-5')-尿苷 鸟苷酰-(3'-5')-3'-鸟苷酸 鸟苷酰(3'-5')尿苷3'-单磷酸酯 鸟苷三磷酸锂 鸟苷5'-硫代二磷酸酯 鸟苷5'-三磷酸酯锰盐 鸟苷5'-[氢(膦酰甲基)膦酸酯]钠盐 鸟苷3'-(三氢二磷酸酯),5'-(三氢二磷酸酯) 鸟苷2’,3’-环单磷酸酯三乙胺盐 鸟苷-5’-二磷酸 鸟苷-5'-三磷酸二钠盐 鸟苷-5'-O-(2-硫代三磷酸)三锂盐 鸟苷-3,5-环单磷酸单钠盐 鸟苷-3',5'-环单硫代磷酸酯 Rp-异构体钠盐 鸟苷,N,N-二甲基-6-O-[2-(4-硝基苯基)乙基]- 鸟苷(5')四磷酰(5')鸟苷 鸟苷 5'-(四氢三磷酸酯-P''-32P) 鸟苷 5'-(四氢 5-硫代三磷酸酯) 鸟苷 2',3',5'-三苯甲酸酯 鸟苷 鸟氨酸,乙基酯(9CI) 鸟嘌呤核糖苷-3’,5’-环磷酸酯 鲁西他滨 马来酸恩替卡韦 马兜铃内酰胺A 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺式-玉米素-D-核糖甙 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 非阿尿苷5’-单磷酸酯 非阿尿苷 非西他滨 阿糖腺苷2',3',5'-三乙酸酯 阿糖腺苷 2',3'-二乙酸酯 阿糖腺苷 阿糖腺苷 阿糖胞苷杂质6 阿糖胞苷杂质19 阿糖胞苷杂质17 阿糖胞苷杂质13